Five-Year watch: does a Wound-Healing gel change skin cancer odds for Fragile-Skin patients?

NCT ID NCT06423573

Summary

This study aims to understand if using the topical gel Filsuvez affects the risk of developing skin cancers in people with severe forms of Epidermolysis Bullosa (EB), a condition that causes extremely fragile, blistering skin. Researchers will follow about 580 patients with EB for up to 5 years, observing those who use Filsuvez and those who receive other standard treatments. The goal is to gather real-world information on skin cancer rates to help guide future care for this vulnerable group.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EPIDERMOLYSIS BULLOSA, DYSTROPHIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CHU de Toulouse, Hôpital Larrey

    RECRUITING

    Toulouse, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Guy's and St Thomas' NHS Foundation Trust

    RECRUITING

    London, United Kingdom

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Hospital Clinic, Barcelona

    RECRUITING

    Barcelona, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Hospital San Juan de Dios (Barcelona)

    RECRUITING

    Barcelona, Spain

    Contact Email: •••••@•••••

    Contact

  • Hospital of Skin and Venereal Diseases of Thessaloniki

    RECRUITING

    Thessaloniki, Greece

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.